Pfizer Inc. closed 19.06% short of its 52-week high of $31.54, which the company reached on July 30th.
Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback